Prediction of Myocardial Injury After Laparoscopic Pheochromocytoma/ParaGangLioma Resection

Last updated: March 6, 2023
Sponsor: Peking Union Medical College Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Neuroendocrine Carcinoma

Treatment

N/A

Clinical Study ID

NCT05752773
2022-PUMCH-B-0071
  • Ages 18-85
  • All Genders

Study Summary

This observational study was conducted in patients undergoing elective laparoscopic pheochromocytoma/paraganglioma(PPGL) resection. It mainly answers the following two main questions:

  1. What are the risk factors for myocardial injury after laparoscopic PPGL resection?

  2. How to establish the myocardial injury prediction model of laparoscopic PPGL resection?

Participants were not required to perform additional research work other than the usual postoperative follow-up within 30 days after surgery. No control group was set in this study, and no additional clinical intervention was performed.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Scheduled for Laparoscopic PPGL resection

Exclusion

Exclusion Criteria:

  1. Open or laparoscopic conversion to open PPGL resection was excluded
  2. Cardiac paraganglioma was excluded
  3. History of congenital heart disease or cardiac surgery was excluded
  4. Patients with preoperative troponin/hypersensitive troponin elevation were excluded
  5. Carotid body tumor and accessory ganglioma of jugular tympanum without endocrinefunction were excluded

Study Design

Total Participants: 700
Study Start date:
February 06, 2023
Estimated Completion Date:
May 31, 2025

Study Description

MI-PPGL is a single-center observational ambispective cohort study.On the basis of retrospective study, the research team plans to build a structured database to investigate the incidence of myocardial injury in laparoscopic PPGL-resection, and further analyze myocardial injury related risk factors. In particular, timing data such as vital signs(blood pressure,heart rate)will be included to construct an efficient and robust myocardial injury prediction model. At the same time, a prospective cohort study is carried out to verify the model, so as to test the prediction ability of myocardial injury and reduce the incidence of myocardial injury.

The investigators expect to enroll 700 patients, including at least 550 patients retrospectively and 150 patients prospectively.In this study, the main endpoint events of the prediction model are binary outcome. Conservatively estimated according to the "10EPV" principle, that is, each predictive factor included in the model needs at least 10 positive outcome endpoint for estimation (10 events per variable). The investigators expected 5 to 8 predictors to be included in the model, and at least 80 positive events to be included. The incidence of perioperative myocardial injury is 12~20%, so the estimated sample size was at least 666 patients. Considering the absence of data or subject withdrawal from the study. so the investigators expected to include 700 patients, including at least 550 retrospectively and 150 prospectively.

STATA (version 15.0; Stata Corp., TX, USA) and R 3.6.1 software (R Foundation for Statistical Computing, Vienna, Austria) will be used for statistical analysis. Binary logistic regression was used to screen risk factors and stratify risk levels. P<0.05 was considered statistically significant. For predictive modeling, clinical databases were 9:1 or 8: 2. Randomly split into training samples and verification samples. In the training samples, optimal subset method and LASSO regression will be used for feature selection.Receiver operating characteristic curve (ROC curve) was used to represent the model differentiation, and Nomogram was used to represent the predictive factors of multiple logistic regression. In the verification samples, Hosmer-Lemeshow goodness of fit test was used to test the calibration degree of the model, and P>0.05 was the acceptable level of estimated fitting of the model. Decision curve analysis (DCA curve) was used to verify the clinical applicability.

Connect with a study center

  • Peking Union Medical College Hospital,Chinese Academy of Medical Science and Peking Union Medical College

    Beijing, Beijing 100730
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.